- 2025-04-12 17:52Lyoniside 34425-25-7
- 2025-04-12 17:52PARP7/HDACs-IN-1
- 2025-04-12 17:52Exatecan Intermediate 7 182182-32-7
- 2025-04-12 17:52KRAS G12C inhibitor 68 3034851-27-6
- 2025-04-12 17:52Antibacterial agent 83 2413865-92-4
- 2025-04-12 17:52DACN(Tos,Suc-OH) 2109751-68-8
- 2025-04-12 17:52Tesirine intermediate-1 1430738-05-8
- 2025-04-12 17:52Uncaric acid (6β,19α-Dihydroxyursolic acid) 123135-05-7
- 2025-04-12 17:52RI-2 1417162-36-7
- 2025-04-12 17:52KIF18A-IN-9 3034541-82-4
- 2025-04-12 17:52Ethidium bromide 1239-45-8
- 2025-04-12 17:52Cys-αvβ6-BP TFA
- 2025-04-12 17:52PARP-IN-1 (3-aminobenzamide; 3-ABA; 3-AB) 3544-24-9
- 2025-04-12 17:52Antitumor agent-76 2787593-12-6
- 2025-04-12 17:522'-Deoxy-2'-fluoro-N1-methyluridine
- 2025-04-12 17:52PDD00017238 1952247-05-0
- 2025-04-12 17:52Isocudraniaxanthone A (Assiguxanthone A) 197447-26-0
- 2025-04-12 17:522',3',5'-Tri-O-benzoyl-2'-β-C-methyl-5-methyl uridine 957535-53-4
- 2025-04-12 17:522,4-D-13C6 (2,4-Dichlorophenoxyacetic acid-13C6) 150907-52-1
- 2025-04-12 17:52NMS-873 1418013-75-8
